semaglutide weight loss fda approval approves first-ever oral GLP-1RA for obesity and chronic management. Meet Wegovy (semaglutide) tablets. https://www.prnewswire.com/news-releases/fda-approves -novo-nordisks-wegovy-pill-the-first-and-only-oral-glp-1-for-weight-loss-in-adults Wegovy pill for weight loss

Though generally well-tolerated, some individuals may experience mild side effects such as nausea or stomach discomfort

These effects are generally mild and tend to improve as the body adjusts to the management

Results are expected to take two to three years

This method results in the inclusion of Medicaid prescriptions and gross spending for: Ozempic, Rybelsus, Mounjaro, Victoza, Trulicity, Wegovy, Zepbound, Saxenda, and generic liraglutide as well as a small number of prescriptions and spending for Adlyxin, Byetta, Bydureon BCise, and Tanzeum (now discontinued)

But many also continued, most commonly by asserting the clinical need exception for a personalized version of the products, much to the frustration of the FDA and brand manufacturers

Heerspink HJL, Stefnsson BV, Correa-Rotter R, et al